Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B.

Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.

2.

Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.

Séraphin MN, Hsu H, Chapman HJ, de Andrade Bezerra JL, Johnston L, Yang Y, Lauzardo M.

BMC Public Health. 2019 Sep 3;19(1):1214. doi: 10.1186/s12889-019-7524-4.

3.

Eliminating tuberculosis: the importance of paediatric tuberculosis surveillance.

Lauzardo M, Nodurft-Froman M.

Lancet Public Health. 2019 Oct;4(10):e485-e486. doi: 10.1016/S2468-2667(19)30148-3. Epub 2019 Aug 21. No abstract available.

4.

Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigation.

Séraphin MN, Norman A, Rasmussen EM, Gerace AM, Chiribau CB, Rowlinson MC, Lillebaek T, Lauzardo M.

EBioMedicine. 2019 Sep;47:293-300. doi: 10.1016/j.ebiom.2019.08.010. Epub 2019 Aug 13.

5.

Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.

Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM, Dowdy DW.

Am J Epidemiol. 2019 Sep 1;188(9):1733-1741. doi: 10.1093/aje/kwz147.

PMID:
31251797
6.

Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.

Goswami ND, Mase S, Griffith D, Bhavaraju R, Lardizabal A, Lauzardo M, Chen L, Wilson J, Chappelle C, Haley CA.

Open Forum Infect Dis. 2019 Apr 4;6(6):ofz167. doi: 10.1093/ofid/ofz167. eCollection 2019 Jun.

7.

Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.

Madrazo-Moya CF, Cancino-Muñoz I, Cuevas-Córdoba B, González-Covarrubias V, Barbosa-Amezcua M, Soberón X, Muñiz-Salazar R, Martínez-Guarneros A, Bäcker C, Zarrabal-Meza J, Sampieri-Ramirez C, Enciso-Moreno A, Lauzardo M, Comas I, Zenteno-Cuevas R.

PLoS One. 2019 Jun 5;14(6):e0213046. doi: 10.1371/journal.pone.0213046. eCollection 2019.

8.

Health care workers' recommendations for strengthening tuberculosis infection control in the Dominican Republic.

Chapman HJ, Veras-Estévez BA, Pomeranz JL, Pérez-Then EN, Marcelino B, Lauzardo M.

Rev Panam Salud Publica. 2018 Dec 28;42:e169. doi: 10.26633/RPSP.2018.169. eCollection 2018.

9.

Mycobacterium bovis BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation.

Gupte A, Matcha A, Lauzardo M.

BMJ Case Rep. 2018 Jul 30;2018. pii: bcr-2018-224462. doi: 10.1136/bcr-2018-224462.

PMID:
30065051
10.

Genomic Investigation of a Mycobacterium tuberculosis Outbreak Involving Prison and Community Cases in Florida, United States.

Séraphin MN, Didelot X, Nolan DJ, May JR, Khan MSR, Murray ER, Salemi M, Morris JG, Lauzardo M.

Am J Trop Med Hyg. 2018 Oct;99(4):867-874. doi: 10.4269/ajtmh.17-0700.

11.

Moving Closer to Tuberculosis Elimination through Institutional Scientific Collaboration: Opportunities for Cuba and the USA.

Chapman HJ, Armas-Pérez LA, Lauzardo M, González-Ochoa ER.

MEDICC Rev. 2018 Apr;20(2):59-63.

12.

Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review.

Pennington KM, Kennedy CC, Chandra S, Lauzardo M, Brito MO, Griffith DE, Seaworth BJ, Escalante P.

J Clin Tuberc Other Mycobact Dis. 2018 Apr 10;11:37-46. doi: 10.1016/j.jctube.2018.04.001. eCollection 2018 May.

13.

Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.

Munro-Rojas D, Fernandez-Morales E, Zarrabal-Meza J, Martínez-Cazares MT, Parissi-Crivelli A, Fuentes-Domínguez J, Séraphin MN, Lauzardo M, González-Y-Merchand JA, Rivera-Gutierrez S, Zenteno-Cuevas R.

PLoS One. 2018 Mar 15;13(3):e0193626. doi: 10.1371/journal.pone.0193626. eCollection 2018.

14.

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Beavers SF, Pascopella L, Davidow AL, Mangan JM, Hirsch-Moverman YR, Golub JE, Blumberg HM, Webb RM, Royce RA, Buskin SE, Leonard MK, Weinfurter PC, Belknap RW, Hughes SE, Warkentin JV, Welbel SF, Miller TL, Kundipati SR, Lauzardo M, Barry PM, Katz DJ, Garrett DO, Graviss EA, Flood JM; Tuberculosis Epidemiologic Studies Consortium.

Ann Am Thorac Soc. 2018 Feb 28. doi: 10.1513/AnnalsATS.201705-405OC. [Epub ahead of print]

15.

Association between Mycobacterium tuberculosis lineage and site of disease in Florida, 2009-2015.

Séraphin MN, Doggett R, Johnston L, Zabala J, Gerace AM, Lauzardo M.

Infect Genet Evol. 2017 Nov;55:366-371. doi: 10.1016/j.meegid.2017.10.004. Epub 2017 Oct 7.

PMID:
28993293
16.

The Role of Powerlessness Among Health Care Workers in Tuberculosis Infection Control.

Chapman HJ, Veras-Estévez BA, Pomeranz JL, Pérez-Then EN, Marcelino B, Lauzardo M.

Qual Health Res. 2017 Dec;27(14):2116-2127. doi: 10.1177/1049732317731317. Epub 2017 Sep 29.

PMID:
28962542
17.

Perceived Barriers to Adherence to Tuberculosis Infection Control Measures among Health Care Workers in the Dominican Republic.

Chapman HJ, Veras-Estévez BA, Pomeranz JL, Pérez-Then EN, Marcelino B, Lauzardo M.

MEDICC Rev. 2017 Jan;19(1):16-22.

18.

Tuberculosis therapy for 2016 and beyond.

Lauzardo M, Peloquin CA.

Expert Opin Pharmacother. 2016 Oct;17(14):1859-72. doi: 10.1080/14656566.2016.1215428. Epub 2016 Aug 19. Review.

PMID:
27457206
19.

Spatiotemporal Clustering of Mycobacterium tuberculosis Complex Genotypes in Florida: Genetic Diversity Segregated by Country of Birth.

Séraphin MN, Lauzardo M, Doggett RT, Zabala J, Morris JG Jr, Blackburn JK.

PLoS One. 2016 Apr 19;11(4):e0153575. doi: 10.1371/journal.pone.0153575. eCollection 2016.

20.

Mycobacterium tuberculosis complex transmission is not associated with recent immigration (≤5 years) in Florida.

Séraphin MN, Lauzardo M.

Infect Genet Evol. 2015 Dec;36:547-551. doi: 10.1016/j.meegid.2015.08.038. Epub 2015 Sep 8.

PMID:
26325684
21.

Is the Beijing strain of Mycobacterium tuberculosis associated with cavitary lung disease?

Chapman HJ, Phillips SA, Hosford JL, Séraphin MN, Lauzardo M.

Infect Genet Evol. 2015 Jul;33:1-5. doi: 10.1016/j.meegid.2015.04.012. Epub 2015 Apr 16.

PMID:
25891279
22.

Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.

Zenteno-Cuevas R, Xochihua-Gonzalez O, Cuevas-Córdoba B, Victoria-Cota NL, Muñiz-Salazar R, Montero H, Hamsho-Díaz P, Lauzardo M.

Int J Antimicrob Agents. 2015 Jun;45(6):671-3. doi: 10.1016/j.ijantimicag.2015.02.006. Epub 2015 Mar 6. No abstract available.

PMID:
25819011
23.

Transmissibility of tuberculosis among school contacts: an outbreak investigation in a boarding middle school, China.

Ma MJ, Yang Y, Wang HB, Zhu YF, Fang LQ, An XP, Wan KL, Whalen CC, Yang XX, Lauzardo M, Zhang ZY, Cao JF, Tong YG, Dai EH, Cao WC.

Infect Genet Evol. 2015 Jun;32:148-55. doi: 10.1016/j.meegid.2015.03.001. Epub 2015 Mar 7.

24.

Optimizing the dose of rifapentine to treat tuberculosis. It's elementary.

Lauzardo M, Ashkin D.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):251-2. doi: 10.1164/rccm.201412-2257ED. No abstract available.

PMID:
25635488
25.

Hepatotoxicity from antituberculous therapy in the elderly: a systematic review.

Hosford JD, von Fricken ME, Lauzardo M, Chang M, Dai Y, Lyon JA, Shuster J, Fennelly KP.

Tuberculosis (Edinb). 2015 Mar;95(2):112-22. doi: 10.1016/j.tube.2014.10.006. Epub 2014 Dec 18. Review.

26.

Description of the population structure and genetic diversity of tuberculosis in Estado de México, a low prevalence setting from Mexico.

Zenteno-Cuevas R, Mendoza-Damián F, Muñoz IC, Enciso-Moreno L, Pérez-Navarro LM, Ramírez-Hernández MD, Vázquez-Medina K, Widrobo-García L, Lauzardo M, Enciso-Moreno JA.

APMIS. 2015 Feb;123(2):116-22. doi: 10.1111/apm.12312. Epub 2014 Sep 25.

PMID:
25257651
27.

Advances in diagnosis and treatment of latent tuberculosis infection.

Chapman HJ, Lauzardo M.

J Am Board Fam Med. 2014 Sep-Oct;27(5):704-12. doi: 10.3122/jabfm.2014.05.140062.

28.

Anticipated tuberculosis stigma among health professionals and Haitian patients in South Florida.

Coreil J, Lauzardo M, Heurtelou M.

J Health Care Poor Underserved. 2012 May;23(2):636-50. doi: 10.1353/hpu.2012.0046.

29.

Antituberculosis therapy for 2012 and beyond.

Lauzardo M, Peloquin CA.

Expert Opin Pharmacother. 2012 Mar;13(4):511-26. doi: 10.1517/14656566.2012.657176. Epub 2012 Feb 15. Review.

30.

Web-accessible database of hsp65 sequences from Mycobacterium reference strains.

Dai J, Chen Y, Lauzardo M.

J Clin Microbiol. 2011 Jun;49(6):2296-303. doi: 10.1128/JCM.02602-10. Epub 2011 Mar 30.

31.

Structural forces and the production of TB-related stigma among Haitians in two contexts.

Coreil J, Mayard G, Simpson KM, Lauzardo M, Zhu Y, Weiss M.

Soc Sci Med. 2010 Oct;71(8):1409-17. doi: 10.1016/j.socscimed.2010.07.017. Epub 2010 Aug 5.

32.

Stigma and Therapy Completion for Latent Tuberculosis among Haitian-origin Patients.

Coreil J, Lauzardo M, Clayton H.

Fla Public Health Rev. 2010 Jan;7:32-38. Epub 2010 Apr 8.

33.

Will new TB tests be effective in HIV-infected individuals?

Lauzardo M.

HIV Clin. 2009 Spring;21(2):13-4. No abstract available.

PMID:
19517623
34.

Consider rifampin BUT be cautious.

Ashkin D, Julien J, Lauzardo M, Hollender E.

Chest. 2006 Dec;130(6):1638-40. No abstract available.

PMID:
17166975
35.

Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida.

Coreil J, Lauzardo M, Heurtelou M.

J Immigr Health. 2004 Apr;6(2):63-9.

PMID:
15014223
36.

Who dunnit? The changing face of tuberculosis control utilizing restriction fragment length polymorphism.

Lauzardo M, Hollender ES, Narita M, Ashkin D.

Chest. 2001 Dec;120(6):1765-8. No abstract available.

PMID:
11742897
37.

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

Narita M, Alonso P, Lauzardo M, Hollender ES, Pitchenik AE, Ashkin D.

Chest. 2001 Aug;120(2):343-8.

PMID:
11502627
38.

Transmission of Mycobacterium tuberculosis to a funeral director during routine embalming.

Lauzardo M, Lee P, Duncan H, Hale Y.

Chest. 2001 Feb;119(2):640-2.

PMID:
11171750
39.

Phthisiology at the dawn of the new century.

Lauzardo M, Ashkin D.

Chest. 2000 May;117(5):1455-73. Review.

PMID:
10807837
40.

Treatment of nocturnal leg cramps.

Brunetti LL, Lauzardo MG, Baucom MP, McDuffie SR, Norton HJ.

Arch Intern Med. 1994 May 9;154(9):1037-8. No abstract available.

PMID:
8179448

Supplemental Content

Loading ...
Support Center